Straumann Holding AG (OTCMKTS:SAUHY) Sees Significant Decrease in Short Interest

Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) was the target of a significant decrease in short interest during the month of May. As of May 29th, there was short interest totaling 30,585 shares, a decrease of 85.1% from the May 14th total of 205,953 shares. Based on an average daily trading volume, of 206,959 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are sold short.

Straumann Stock Down 2.0%

Shares of SAUHY traded down $0.24 during mid-day trading on Wednesday, reaching $11.72. The company had a trading volume of 10,118 shares, compared to its average volume of 174,697. The firm has a fifty day simple moving average of $11.07 and a 200-day simple moving average of $11.48. Straumann has a fifty-two week low of $9.44 and a fifty-two week high of $14.11.

Analyst Ratings Changes

A number of brokerages have recently issued reports on SAUHY. Citigroup reiterated a “sell” rating on shares of Straumann in a research note on Thursday, April 23rd. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research report on Tuesday, April 14th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Straumann presently has a consensus rating of “Reduce”.

Check Out Our Latest Stock Analysis on SAUHY

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Featured Stories

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.